Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,290 total articles
Archer Aviation (ACHR) trades near $4.90 after a defense partnership rally, but the company is burning cash at a pace that makes the current equity base vulnerable to dilution or a sharp re-price. Market cap sits around $4.28B while trailing losses, negative free cash flow, and quarterly burn headlines point to material near-term risk. This trade i…
Tesla pulled back after a Q2 miss and margin weakness, but today's price sits in oversold territory with a delivery-driven path to recovery. This trade idea buys near the current dip with a clear stop and a mid-term target, prioritizing production and delivery trends over near-term margin volatility.
RPM is showing durable margin expansion, strong free cash flow and continued record quarterly profits. With a market cap near $13.8B, a P/E around 20-21 and an improving end-market mix, the stock looks arguably undervalued relative to its cash generation and dividend durability. I am upgrading RPM to a constructive trade idea - a long with a clear …
Pfizer is wrestling with a real patent cliff and pipeline timing risk, yet the market has pushed valuation and sentiment to levels that understate the company’s cash generation and dividend support. With a market cap near $141B, EV/EBITDA at 8.5 and free cash flow of $9.485B, PFE looks like a tactical long for patient, income-focused traders willin…
Block is underappreciated for the pace of revenue growth and sustained margin expansion coming from Cash App monetization and Seller efficiency. I recommend a tactical long with an entry at $90.00, stop at $75.00 and a primary target of $120.00 over a 180-trading-day horizon.
DISCO (DSCSY) sold off after a results miss, but the pullback looks overdone. Market-cap $39.7B, P/E ~52, and recent technical oversold readings create a defined entry for a mid-term rebound. Trade plan: enter $36.63, stop $32.00, target $48.00, horizon mid term (45 trading days).
Tantalus Systems offers hardware and software that squeeze higher efficiency and resilience out of data-center power stacks. We see a tactical long opportunity: entry $6.50, stop $4.90, target $9.75 over a mid-term 45-trading-day horizon. The trade plays adoption of energy-efficient power distribution and rising capex in hyperscale and colo environ…
Palantir is trading below its 52-week high after a pullback to $106.37. Fundamentals show heavy growth, high profitability metrics, and strong free cash flow; technicals are mixed. This trade idea takes a long stance on the view that commercial bookings are stabilizing and the company’s AI operating layer can drive re-acceleration. Trade plan inclu…
Bank of Hawaii (BOH) is showing the characteristics of a regional bank positioned to benefit as lending yields re-price higher. With a clean balance sheet, EPS near $5, and a dividend yield in the low single digits, the stock offers a measurable risk-reward for a mid-term swing trade that leans long while rates continue to favor net interest income…
AT&T is trading at a distressed-looking multiple despite quarter-over-quarter margin improvement and a fiber-driven subscriber ramp. With a P/E of ~7.4, a $10B buyback boost, 5%+ yield and $13.3B in free cash flow, the stock looks attractive for a mid-to-long-term tactical long. This trade idea lays out an entry, stop, targets and the key catalysts…
MacroGenics (MGNX) has been whipsawed by clinical headlines — most recently a partial FDA hold on the LINNET study — but the company’s pipeline and modest enterprise value create a tactical long opportunity for disciplined traders. I outline an entry at $3.95, stop at $3.20 and a target of $5.20 over a mid-term 45 trading day horizon, with explicit…
ASML's monopoly in EUV lithography and accelerating AI-driven wafer fab spending create a clearer path to sustained revenue and margin expansion. We upgrade to Buy and propose a long-term structured trade with defined entry, target, and stop, reflecting a favorable risk/reward into the next 180 trading days.
Modine is pivoting toward high-margin data center thermal solutions at a time when direct-to-chip and immersion cooling demand is surging. A large multi-year hyperscale deal and a planned spinoff of low-margin assets justify a premium valuation if Modine converts backlog into recurring revenue and sustains margins. This trade idea outlines an actio…
Selective Insurance (SIGI) offers a reasonable entry point now: cheap relative to earnings, healthy free cash flow, and meaningful exposure growth. I recommend a tactical long entry at $95.00 with a stop at $88.00 and a target of $106.00 over a mid-term trade window, while monitoring H2 underwriting guidance and reserve trends closely.
AT&T (T) remains a high-cash-flow, income-oriented name worth accumulating on weakness. The telecom's scale, steady wireless cash flow and ongoing fiber deployment support a durable dividend. This trade recommends adding at $13.80 with a $16.50 target and a $12.50 stop, sized for income-oriented portfolios that can tolerate earnings variability and…
Novo Nordisk (NVO) is trading at a reasonable multiple versus its growth trajectory. A sensitivity-based read of oral Wegovy's gross-profit potential — combined with an active share buyback, a 2.39% dividend yield and improving supply dynamics — supports a modest long position. This trade plan balances upside from volume-driven growth with downside…
Chemung Financial looks like a classic under-the-radar regional bank: steady dividends, strong free cash flow relative to its market cap, modest leverage and an improving technical momentum. At $81.10 today, the setup favors a long with a clear entry, stop and a conservative target that assumes modest multiple expansion and continued FCF generation…
Nebius is trading like a speculative play while delivering explosive revenue growth and strategic partnerships that deserve a premium. This trade targets a re-rating catalyst over the next 45 trading days supported by fundamentals, Nvidia backing, and clear demand for GPU capacity.
Chemung Financial (CHMG) has pushed to a 52-week high after a string of positive dividends, tightening technicals and improving credit metrics. With a market cap near $392M, a P/E in the low-20s, and free cash flow of roughly $47M, the risk-reward favors a mid-term long. This trade idea lays out an entry at $81.00, a stop at $73.00, and a target of…
Valvoline is a cash-generative aftermarket leader pairing retail lubricants with a growing fast-lube service network. At $39.50, the stock offers exposure to steady industry growth, improving unit economics at Valvoline Instant Oil Change, and a reasonable path to margin expansion. The trade: enter around $39.00, stop at $35.00, target $48.00 over …
Eledon Pharmaceuticals sits at an unusual intersection: a clinical-stage biotech with a broadly applicable immunology asset (tegoprubart) that produced encouraging Phase 2 kidney transplant data and was used in a high-profile pig-to-human transplant. With a market cap near $276M and a clean balance sheet, ELDN is a speculative long for investors wi…
Canadian National (CNI) reported a clean Q2 with double-digit EPS growth, raised guidance, and announced a quarterly dividend that keeps income-oriented buyers interested. Regulatory developments that slow a large U.S. rail merger and a new BHP potash logistics win reduce competitive risk. Technically, CN sits above its key moving averages with bul…
HealthEquity (HQY) has shown durable earnings momentum and balance-sheet-driven growth in HSAs and invested assets. With HSA assets at $36.5B, investments up 26% year-over-year and free cash flow near $457M, the company is executing. Valuation is full but not extreme: market cap roughly $7.9B and a P/E around 34x. For traders willing to accept shor…
AXT has moved from obscure to indispensable as indium phosphide wafers become a bottleneck for AI optics. The company’s revenue cadence and capacity moves argue for a near-term beat; the stock already prices a perfect outcome. I recommend a tactical long ahead of Q2 with a strict stop to manage the stretched valuation and execution risk.
ServiceNow is trading well below its 52-week high despite accelerating revenue and strong free cash flow. The stock's high multiple reflects AI-driven growth expectations; this trade targets a disciplined entry at $99.50 with a $130 target over 180 trading days and a $90 stop, balancing upside from product-led AI adoption with valuation risk and ne…
